CTNNA3 and myeloid sarcoma: Given the broad range of phenotypes ascribed to CTNNA3, it is important to note that obligate carrier II-7 developed bronchitis, cancer and osteoporosis, whereas III-10 and III-11 developed cancer and rheumatic fever, respectively, in addition to MS.